Download PDF
CC BY-NC-ND 4.0 · Sleep Sci 2019; 12(01): 53-56
DOI: 10.5935/1984-0063.20190049
Case Report

The Effectiveness of Melatonin in Head Banging: A case report

Ozge Metin
1   School of Medicine, Cukurova University, Department of Child and Adolescent Psychiatry - ADANA - Adana - Turkey.
,
Ezgi Eynalli-Gok
1   School of Medicine, Cukurova University, Department of Child and Adolescent Psychiatry - ADANA - Adana - Turkey.
,
Canan Kuygun-Karci
1   School of Medicine, Cukurova University, Department of Child and Adolescent Psychiatry - ADANA - Adana - Turkey.
,
Aysegul Yolga-Tahiroglu
1   School of Medicine, Cukurova University, Department of Child and Adolescent Psychiatry - ADANA - Adana - Turkey.
› Author Affiliations
› Further Information
   Permissions and Reprints

Head banging is one of the three typical subtypes of rhythmic movement disorder. It typically involves anteroposterior movements of the head. Rhythmic movement disorder usually resolves in early childhood but less commonly persists into adolescence and adulthood. Although benzodiazepines commonly used, the universal effectiveness of any pharmacologic agent has not been approved. Herein, we present an 8-year-old girl patient suffered from head banging who responded to melatonin after in failure to imipramine treatment. Although nocomplete remission has been obtained, this is the first melatonin trial in a child patient with headbanging.

Sleep - Melatonin - Child


Publication History

Received: 10 April 2018

Accepted: 10 December 2018

Article published online:
31 October 2023

© 2023. Brazilian Sleep Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 

  • REFERENCES

  • 1 Trotti LM. Restless Legs Syndrome and Sleep-Related Movement Disorders. Continuum (Minneap Minn). 2017;23(4, Sleep Neurology):1005-16.
  • 2 American Academy of Sleep Medicine. International Classification of Sleep Disorders. 3rd ed. Darien: American Academy of Sleep Medicine; 2014.
  • 3 Hoban TF. Rhythmic movement disorder in children. CNS Spectr. 2003;8(2):135-8.
  • 4 Silber MH. Sleep-related movement disorders. Continuum (Minneap Minn). 2013;19(1 Sleep Disorders):170-84.
  • 5 Haywood PM, Hill CM. Rhythmic movement disorder: managing the child who head-bangs to get to sleep. Paediatr Child Health. 2012;22(5):207-10.
  • 6 Merlino G, Gigli GL. Sleep-related movement disorders. Neurol Sci. 2012;33(3):491-513.
  • 7 Drake ME Jr. Jactatio nocturna after head injury. Neurology. 1986;36(6):867-8.
  • 8 Alves RS, Alóe F, Silva AB, Tavares SM. Jactatio capitis nocturna with persistence in adulthood. Case report. Arq Neuropsiquiatr. 1998;56(3B):655-7.
  • 9 Öner P, Barut Y, Öner Ö, Üneri ÖŞ, Bodur Ş, Turgut S, et al. Çocuklarda Uyku Ölçeği’nin Geçerlik ve Güvenirliği. Klinik Psikofarmakol Bulteni. 2009;19(4):382-95.
  • 10 Dyken ME, Lin-Dyken DC, Yamada T. Diagnosing rhythmic movement disorder with video-polysomnography. Pediatr Neurol. 1997;16(1):37-41.
  • 11 Yeh SB, Schenck CH. Atypical headbanging presentation of idiopathic sleep related rhythmic movement disorder: three cases with video-polysomnographic documentation. J Cin Sleep Med. 2012;8(4):403-11.
  • 12 Stepanova I, Nevsimalova S, Hanusova J. Rhythmic movement disorder in sleep persisting into childhood and adulthood. Sleep. 2005;28(7):851-7.
  • 13 Zisapel N. Melatonin-dopamine interactions: from basic neurochemistry to a clinical setting. Cell Mol Neurobiol. 2001;21(6):605-16.
  • 14 Rao ML, Gross G, Strebel B, Bräunig P, Huber G, Klosterkötter J. Serum amino acids, central monoamines, and hormones in drug-naive, drugfree, and neuroleptic-treated schizophrenic patients and healthy subjects. Psychiatry Res. 1990;34(3):243-57.
  • 15 Shamir E, Barak Y, Shalman I, Laudon M, Zisapel N, Tarrasch R, et al. Melatonin treatment for tardive dyskinesia: a double-blind, placebo-controlled, crossover study. Arch Gen Psychiatry. 2001;58(11):1049-52.
  • 16 Dawson D, Armstrong SM. Chronobiotics--drugs that shift rhythms. Pharmacol Ther. 1996;69(1):15-36.
  • 17 Kunz D, Bes F. Exogenous melatonin in periodic limb movement disorder: an open clinical trial and a hypothesis. Sleep. 2001;24(2):183-7.
  • 18 Kunz D, Bes F. Melatonin as a therapy in REM sleep behavior disorder patients: an open-labeled pilot study on the possible influence of melatonin on REM-sleep regulation. Mov Disord. 1999;14(3):507-11.
  • 19 Claustrat B, Leston J. Melatonin: Physiological effects in humans. Neurochirurgie. 2015;61(2-3):77-84.
  • 20 Pelin Z, Karataş S, Kesebir S. Jactatio corporis nocturna and dissociative disorder: a case report. Turk Psikiyatri Derg. 2012;23(2):141-4.